BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17382220)

  • 1. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.
    Wolff BG; Weese JL; Ludwig KA; Delaney CP; Stamos MJ; Michelassi F; Du W; Techner L
    J Am Coll Surg; 2007 Apr; 204(4):609-16. PubMed ID: 17382220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
    Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
    Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
    Lee CT; Chang SS; Kamat AM; Amiel G; Beard TL; Fergany A; Karnes RJ; Kurz A; Menon V; Sexton WJ; Slaton JW; Svatek RS; Wilson SS; Techner L; Bihrle R; Steinberg GD; Koch M
    Eur Urol; 2014 Aug; 66(2):265-72. PubMed ID: 24630419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.
    Ludwig K; Enker WE; Delaney CP; Wolff BG; Du W; Fort JG; Cherubini M; Cucinotta J; Techner L
    Arch Surg; 2008 Nov; 143(11):1098-105. PubMed ID: 19015469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of gastrointestinal recovery after bowel resection and total abdominal hysterectomy: pooled results from the placebo arms of alvimopan phase III North American clinical trials.
    Wolff BG; Viscusi ER; Delaney CP; Du W; Techner L
    J Am Coll Surg; 2007 Jul; 205(1):43-51. PubMed ID: 17617331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
    Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
    Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.
    Delaney CP; Weese JL; Hyman NH; Bauer J; Techner L; Gabriel K; Du W; Schmidt WK; Wallin BA;
    Dis Colon Rectum; 2005 Jun; 48(6):1114-25; discussion 1125-6; author reply 1127-9. PubMed ID: 15906123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
    Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
    J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion.
    Vora AA; Harbin A; Rayson R; Christiansen K; Ghasemian R; Hwang J; Verghese M
    Can J Urol; 2012 Jun; 19(3):6293-8. PubMed ID: 22704317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does alvimopan enhance return of bowel function in laparoscopic right colectomy?
    Abodeely A; Schechter S; Klipfel A; Vrees M; Lagares-Garcia J
    Am Surg; 2011 Nov; 77(11):1460-2. PubMed ID: 22196657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alvimopan: a peripherally acting mu-opioid receptor antagonist.
    Leslie JB
    Drugs Today (Barc); 2007 Sep; 43(9):611-25. PubMed ID: 17940638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alvimopan for the management of postoperative ileus.
    Leslie JB
    Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
    Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
    J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus.
    Tan EK; Cornish J; Darzi AW; Tekkis PP
    Aliment Pharmacol Ther; 2007 Jan; 25(1):47-57. PubMed ID: 17042776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.
    Absher RK; Gerkin TM; Banares LW
    Ann Pharmacother; 2010 Nov; 44(11):1701-8. PubMed ID: 20858770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis.
    Ludwig K; Viscusi ER; Wolff BG; Delaney CP; Senagore A; Techner L
    World J Surg; 2010 Sep; 34(9):2185-90. PubMed ID: 20526599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use.
    Senagore AJ; Bauer JJ; Du W; Techner L
    Surgery; 2007 Oct; 142(4):478-86. PubMed ID: 17950339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection.
    Delaney CP; Craver C; Gibbons MM; Rachfal AW; VandePol CJ; Cook SF; Poston SA; Calloway M; Techner L
    Ann Surg; 2012 Apr; 255(4):731-8. PubMed ID: 22388106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of alvimopan for prevention and management of postoperative ileus.
    Touchette DR; Yang Y; Tiryaki F; Galanter WL
    Pharmacotherapy; 2012 Feb; 32(2):120-8. PubMed ID: 22392420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery.
    Vaughan-Shaw PG; Fecher IC; Harris S; Knight JS
    Dis Colon Rectum; 2012 May; 55(5):611-20. PubMed ID: 22513441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.